Genetic Testing Services Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, and Others), Disease (Cancer, Metabolic Diseases, Cardiovascular Diseases, and Other Diseases), Service Provider (Hospital-Based Laboratories, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America)
The genetic testing services market size is expected to grow from US$ 3.425 billion in 2022 to US$ 10.556 billion by 2030; it is estimated to record a CAGR of 15.1% during 2022-2030.
The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.
Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can majorly be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and the presence of a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.
The quality and availability of genetic services may differ between high-income countries and low- to middle-income countries. For instance, in the US, Australia, Canada, the UK, and other European countries, genetic services are well-advanced, established, and extensive. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services that are offered in multiple settings still need improved systems of assessment.
The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players are focusing on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries, as it will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in the field of preventive medicine and clinical genetics into its portfolio.
The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016–2020) for the country's economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.
Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.
As of 2018, there were ~75,000 genetic tests available in the market, with nearly ten new tests entering the market every day. As per the study 'Trends in Availability of Genetic Tests in the United States, 2012–2022,' published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to analyze and understand clinical data correctly in fields such as radiology and cardiology.
Many of the consumer-facing genetic testing technologies that are available in the market are using machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and prior to the introduction of machine learning, many of these tasks were pretty tricky. AI offers great potential when it comes to analyzing genetic data and supporting clinical specialists in making diagnoses.
Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways through which machine learning and AI can add to a better understanding of genetics and genomics. Thus, through the successful integration of these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.
Service Provider-Based Insights
Based on service providers, the genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. In 2022, the hospital-based laboratories segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2030. Hospital-based laboratories are genetic testing service providers that operate within a hospital setting. Hospital laboratories can be segmented by type of testing and staffed by personnel trained in particular specialties. For instance, some sections can focus on microbiology, hematology, chemistry, and blood banking. At the same time, some units may perform highly specialized genetic tests using electron microscopy and immunohistochemistry, and others can focus on surgical pathology and cytology, which are all linked with the investigation of cell and tissue structure. The market growth for the segment can be due to the compulsory newborn screening for genetic disorders and the growing prevalence of cancer in many regions.
Seattle Children's Hospital in Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region provides comprehensive genetic testing and consultative services to healthcare workers and families. Their genetics laboratories consist of molecular genetics, cytogenetics, biochemical genetics, and a research and development laboratory devoted to bringing the most existing and specific research tests into the clinical field. Overall, these laboratories play a crucial role in helping to diagnose genetic disorders, guide treatment decisions, and improve patient outcomes.
Centers for Disease Control and Prevention, the US Food and Drug Administration, and the World Health Organization are among the primary and secondary sources referred to while preparing the genetic testing services market report.
The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.
Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can majorly be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and the presence of a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.
The quality and availability of genetic services may differ between high-income countries and low- to middle-income countries. For instance, in the US, Australia, Canada, the UK, and other European countries, genetic services are well-advanced, established, and extensive. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services that are offered in multiple settings still need improved systems of assessment.
The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players are focusing on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries, as it will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in the field of preventive medicine and clinical genetics into its portfolio.
The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016–2020) for the country's economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.
Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.
As of 2018, there were ~75,000 genetic tests available in the market, with nearly ten new tests entering the market every day. As per the study 'Trends in Availability of Genetic Tests in the United States, 2012–2022,' published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to analyze and understand clinical data correctly in fields such as radiology and cardiology.
Many of the consumer-facing genetic testing technologies that are available in the market are using machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and prior to the introduction of machine learning, many of these tasks were pretty tricky. AI offers great potential when it comes to analyzing genetic data and supporting clinical specialists in making diagnoses.
Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways through which machine learning and AI can add to a better understanding of genetics and genomics. Thus, through the successful integration of these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.
Service Provider-Based Insights
Based on service providers, the genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. In 2022, the hospital-based laboratories segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2030. Hospital-based laboratories are genetic testing service providers that operate within a hospital setting. Hospital laboratories can be segmented by type of testing and staffed by personnel trained in particular specialties. For instance, some sections can focus on microbiology, hematology, chemistry, and blood banking. At the same time, some units may perform highly specialized genetic tests using electron microscopy and immunohistochemistry, and others can focus on surgical pathology and cytology, which are all linked with the investigation of cell and tissue structure. The market growth for the segment can be due to the compulsory newborn screening for genetic disorders and the growing prevalence of cancer in many regions.
Seattle Children's Hospital in Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region provides comprehensive genetic testing and consultative services to healthcare workers and families. Their genetics laboratories consist of molecular genetics, cytogenetics, biochemical genetics, and a research and development laboratory devoted to bringing the most existing and specific research tests into the clinical field. Overall, these laboratories play a crucial role in helping to diagnose genetic disorders, guide treatment decisions, and improve patient outcomes.
Centers for Disease Control and Prevention, the US Food and Drug Administration, and the World Health Organization are among the primary and secondary sources referred to while preparing the genetic testing services market report.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. GENETIC TESTING SERVICES MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. GENETIC TESTING SERVICES MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Genetic Diseases
5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
5.2 Market Restraints
5.2.1 Social and Ethical Implications of Genetic Testing
5.2.2 Affordability of Genetic Services
5.3 Market Opportunities
5.3.1 Untapped Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence-Powered Genetic Testing
5.5 Impact Analysis:
6. GENETIC TESTING SERVICES MARKET - GLOBAL MARKET ANALYSIS
6.1 Genetic Testing Services Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL GENETIC TESTING SERVICES MARKET – REVENUE AND FORECAST TO 2030 – BY SERVICE TYPE
7.1 Overview
7.2 Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
7.3 Predictive Testing
7.3.1 Overview
7.3.2 Predictive Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Carrier Testing
7.4.1 Overview
7.4.2 Carrier Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Prenatal Testing
7.5.1 Overview
7.5.2 Prenatal Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Newborn Screening
7.6.1 Overview
7.6.2 Newborn Screening: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL GENETIC TESTING SERVICES MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE
8.1 Overview
8.2 Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cardiovascular Diseases
8.4.1 Overview
8.4.2 Cardiovascular Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Metabolic Diseases
8.5.1 Overview
8.5.2 Metabolic Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Other Diseases
8.6.1 Overview
8.6.2 Other Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL GENETIC TESTING SERVICES MARKET – REVENUE AND FORECAST TO 2030 – BY SERVICE PROVIDER
9.1 Overview
9.2 Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
9.3 Hospital-Based Laboratories
9.3.1 Overview
9.3.2 Hospital-Based Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. GENETIC TESTING SERVICES MARKET - GEOGRAPHICAL ANALYSIS
10.1 North America Genetic Testing Services Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.4 North America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.5 North America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6 North America Genetic Testing Services Market, by Country
10.1.6.1 US
10.1.6.1.1 Overview
10.1.6.1.2 US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.3 US: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.1.4 US: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.1.5 US: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6.2 Canada
10.1.6.2.1 Overview
10.1.6.2.2 Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.2.3 Canada: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.2.4 Canada: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.2.5 Canada: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6.3 Mexico
10.1.6.3.1 Overview
10.1.6.3.2 Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.3 Mexico: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.3.4 Mexico: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.3.5 Mexico: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2 Europe Genetic Testing Services Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.4 Europe: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.5 Europe: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6 Europe Genetic Testing Services Market, by Country
10.2.6.1 UK
10.2.6.1.1 Overview
10.2.6.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.3 UK: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.1.4 UK: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.1.5 UK: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Overview
10.2.6.2.2 Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.3 Germany: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.2.4 Germany: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.2.5 Germany: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 Overview
10.2.6.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.3 France: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.3.4 France: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.3.5 France: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Overview
10.2.6.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.3 Italy: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.4.5 Italy: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Overview
10.2.6.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.3 Spain: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.5.5 Spain: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.3 Rest of Europe: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.6.5 Rest of Europe: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3 Asia Pacific Genetic Testing Services Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6 Asia Pacific Genetic Testing Services Market, by Country
10.3.6.1 China
10.3.6.1.1 Overview
10.3.6.1.2 China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.3 China: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.1.4 China: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.1.5 China: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Overview
10.3.6.2.2 Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.3 Japan: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.2.5 Japan: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 Overview
10.3.6.3.2 India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.3 India: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.3.4 India: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.3.5 India: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Overview
10.3.6.4.2 Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.3 Australia: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.4.5 Australia: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 Overview
10.3.6.5.2 South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.3 South Korea: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.5.5 South Korea: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.3 Rest of Asia Pacific: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4 Middle East & Africa Genetic Testing Services Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6 Middle East & Africa Genetic Testing Services Market, by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.3 Saudi Arabia: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.1.4 Saudi Arabia: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.1.5 Saudi Arabia: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.2 UAE
10.4.6.2.1 Overview
10.4.6.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.3 UAE: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.2.4 UAE: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.2.5 UAE: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.3 South Africa
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.3 South Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.3.4 South Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.3.5 South Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.3 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5 South & Central America Genetic Testing Services Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.4 South & Central America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.5 South & Central America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6 South & Central America Genetic Testing Services Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Overview
10.5.6.1.2 Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.3 Brazil: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.1.4 Brazil: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.1.5 Brazil: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.3 Argentina: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.2.4 Argentina: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.2.5 Argentina: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.3 Rest of South & Central America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
11. GENETIC TESTING SERVICES MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Genetic Testing Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Eurofins Scientific SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Exact Sciences Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corp of America Holdings
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4andMe Holding Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ambry Genetics Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Illumina Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NeoGenomics Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. GENETIC TESTING SERVICES MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. GENETIC TESTING SERVICES MARKET - KEY INDUSTRY DYNAMICS
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Genetic Diseases
5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
5.2 Market Restraints
5.2.1 Social and Ethical Implications of Genetic Testing
5.2.2 Affordability of Genetic Services
5.3 Market Opportunities
5.3.1 Untapped Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence-Powered Genetic Testing
5.5 Impact Analysis:
6. GENETIC TESTING SERVICES MARKET - GLOBAL MARKET ANALYSIS
6.1 Genetic Testing Services Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL GENETIC TESTING SERVICES MARKET – REVENUE AND FORECAST TO 2030 – BY SERVICE TYPE
7.1 Overview
7.2 Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
7.3 Predictive Testing
7.3.1 Overview
7.3.2 Predictive Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Carrier Testing
7.4.1 Overview
7.4.2 Carrier Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Prenatal Testing
7.5.1 Overview
7.5.2 Prenatal Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Newborn Screening
7.6.1 Overview
7.6.2 Newborn Screening: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL GENETIC TESTING SERVICES MARKET – REVENUE AND FORECAST TO 2030 – BY DISEASE
8.1 Overview
8.2 Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cardiovascular Diseases
8.4.1 Overview
8.4.2 Cardiovascular Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Metabolic Diseases
8.5.1 Overview
8.5.2 Metabolic Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Other Diseases
8.6.1 Overview
8.6.2 Other Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL GENETIC TESTING SERVICES MARKET – REVENUE AND FORECAST TO 2030 – BY SERVICE PROVIDER
9.1 Overview
9.2 Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
9.3 Hospital-Based Laboratories
9.3.1 Overview
9.3.2 Hospital-Based Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. GENETIC TESTING SERVICES MARKET - GEOGRAPHICAL ANALYSIS
10.1 North America Genetic Testing Services Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.4 North America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.5 North America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6 North America Genetic Testing Services Market, by Country
10.1.6.1 US
10.1.6.1.1 Overview
10.1.6.1.2 US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.3 US: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.1.4 US: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.1.5 US: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6.2 Canada
10.1.6.2.1 Overview
10.1.6.2.2 Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.2.3 Canada: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.2.4 Canada: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.2.5 Canada: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6.3 Mexico
10.1.6.3.1 Overview
10.1.6.3.2 Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.3 Mexico: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.3.4 Mexico: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.3.5 Mexico: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2 Europe Genetic Testing Services Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.4 Europe: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.5 Europe: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6 Europe Genetic Testing Services Market, by Country
10.2.6.1 UK
10.2.6.1.1 Overview
10.2.6.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.3 UK: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.1.4 UK: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.1.5 UK: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Overview
10.2.6.2.2 Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.3 Germany: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.2.4 Germany: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.2.5 Germany: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 Overview
10.2.6.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.3 France: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.3.4 France: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.3.5 France: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Overview
10.2.6.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.3 Italy: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.4.5 Italy: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Overview
10.2.6.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.3 Spain: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.5.5 Spain: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.3 Rest of Europe: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.6.5 Rest of Europe: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3 Asia Pacific Genetic Testing Services Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6 Asia Pacific Genetic Testing Services Market, by Country
10.3.6.1 China
10.3.6.1.1 Overview
10.3.6.1.2 China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.3 China: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.1.4 China: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.1.5 China: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Overview
10.3.6.2.2 Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.3 Japan: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.2.5 Japan: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 Overview
10.3.6.3.2 India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.3 India: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.3.4 India: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.3.5 India: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Overview
10.3.6.4.2 Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.3 Australia: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.4.5 Australia: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 Overview
10.3.6.5.2 South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.3 South Korea: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.5.5 South Korea: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.3 Rest of Asia Pacific: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4 Middle East & Africa Genetic Testing Services Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6 Middle East & Africa Genetic Testing Services Market, by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.3 Saudi Arabia: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.1.4 Saudi Arabia: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.1.5 Saudi Arabia: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.2 UAE
10.4.6.2.1 Overview
10.4.6.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.3 UAE: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.2.4 UAE: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.2.5 UAE: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.3 South Africa
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.3 South Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.3.4 South Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.3.5 South Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.3 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5 South & Central America Genetic Testing Services Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.4 South & Central America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.5 South & Central America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6 South & Central America Genetic Testing Services Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Overview
10.5.6.1.2 Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.3 Brazil: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.1.4 Brazil: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.1.5 Brazil: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.3 Argentina: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.2.4 Argentina: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.2.5 Argentina: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.3 Rest of South & Central America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
11. GENETIC TESTING SERVICES MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Genetic Testing Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Eurofins Scientific SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Exact Sciences Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corp of America Holdings
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4andMe Holding Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ambry Genetics Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Illumina Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NeoGenomics Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
